TScan Therapeutics Announces Upcoming Oral Presentation of Data From the Alloha™ Phase 1 Heme Trial at the 66TH American Society of Hematology Annual Meeting and Exposition
TScan Therapeutics宣佈將在第66屆美國血液學學會年會上進行Alloha™第1期血液試驗數據的口頭報告。
TScan Therapeutics Announces Upcoming Oral Presentation of Data From the Alloha™ Phase 1 Heme Trial at the 66TH American Society of Hematology Annual Meeting and Exposition
TScan Therapeutics宣佈將在第66屆美國血液學學會年會上進行Alloha™第1期血液試驗數據的口頭報告。
譯文內容由第三人軟體翻譯。